No Data
Will The DeepSeek-Frenzy Aided Recovery Last For Airdoc Technology Stock?
Trending Industry Today: CARSGEN-B Leads Gains In Pharmaceutical Companies Stocks
BOCOM INTL: There is significant room for recovery in the mainland pharmaceutical Sector, and the foreign investment environment is expected to improve.
Subsequent bullish policies for finance and medical insurance/commercial insurance are expected to continue to be introduced, and the overall valuation of the sector remains at a historical low, indicating significant room for recovery in the sector, thus giving the mainland pharmaceutical Industry a "leading" rating.
[Brokerage Focus] BOCOM INTL points to new opportunities in the medical Sector driven by AI technology, focusing on innovation related to AI and opportunities for valuation recovery.
Jingu Finance News | BOCOM INTL stated that multiple pharmaceutical companies have integrated DeepSeek, accelerating the implementation of AI + Medical Services. Many companies in the digital medical field, such as Yidu Technology, announced the integration of DeepSeek-R1 model, and Jiangsu Hengrui Pharmaceuticals and INNOVENT BIO also indicated that they will fully carry out DeepSeek application work. Moreover, the National Healthcare Security Administration has reiterated the reform of payment collection. The administration mentioned the achievements of the settlement reform in Jiangxi Province, where the payment collection cycle for medical supply companies has reduced from half a year to 30 days. The bank pointed out that AI large models empower digital medical services companies, showing significant potential in disease diagnosis/detection. At the same time,
Eagle Eye Technology (02251.HK) has appointed Wang Xinfeng as the co-company secretary.
On January 20, Glory Exchange announced that Ms. Yang Wenting has resigned from her position as Co-Secretary of the Company, effective January 20, 2025, to focus on her role as Chief Financial Officer. The Board of Directors also announced that Ms. Wang Xinfeng has been appointed as Co-Secretary of the Company, effective January 20, 2025. The current Co-Secretary, Ms. Su Lishan, will continue to hold her existing position.
On January 8, Eagle Eye Technology (02251.HK) spent 0.212 million Hong Kong dollars to repurchase 0.018 million shares.
On January 8, GC Capital announced that Eagle Eye Technology (02251.HK) spent 0.212 million Hong Kong dollars to repurchase 0.018 million shares.
